Top Tweets for #Affiris
Assessing Immunotherapies Targeting α-Synuclein in Parkinson Disease https://t.co/LPODZ5gjlw via @AJMC_Journal #Affiris #PD01a #PD03A
Sind Sie bereit für Ihre nächste #VentureCapital Capital Investition in den Bereich #Biotechnologie?
Erfahren Sie mehr zu den #MIGFonds und deren Beteiligungsunternehmen im Video!
#Advancecor #Affiris #Amslik #BioNtech #Immatics #Instraction #Isarna #biotech #investments
Positive Ergebnisse der Phase 1-Studie vom MIG Fonds Portfoliounternehmen @AFFiRiSAG mit dem Wirkstoff PD01 zur Behandlung von Parkinson-Patienten!
https://t.co/r46KiqTFNv
#MIGFonds #Affiris #HMW #biotech #parkinson

The Lancet Neurology publishes positive results of AFFiRiS Phase 1 trial with PD01A in PD patients
https://t.co/PpDu96NoJY
#TheLancetNeurology #AFFiRiS #Immunotherapy #Biotechnology #Pharmaceutical #ClinicalTrials #DrugDiscovery #DrugDevelopment #DDW #DrugDiscoveryWorld

Neurobiology of Disease publishes encouraging preclinical results of #AFFiRiS’ #antibody mAB C6-17 to treat #Huntingtonsdisease @ELSneuroscience https://t.co/4AXFVQtIbH

so thanks here to all our paying customers including @IMPvienna @FHCampusWien @fhkrems @C4Dispatches @HookipaPharma #AFFiRiS @Sdt36Suzanne we appreciate your generosity and are happy about all the followers here and @youtube to provide the clout🙏🎥👍📱
Congrats!! @tricentis, @themis_bio, @affirisag, @emarsys, @bitmovin have made to Soonicorn Club 2020: Top Tech Startups In Austria! https://t.co/HiHFhnV6Yk
#Vienna #biotech #cloud #data #platform #tech #startup #soonicorn
#WorldParkinsonsDay: #AFFiRiS developing #PD01 to treat #Parkinsonsdisease, a major unmet medical need “There is a tremendous need for therapies that do not just manage the symptoms”. After a promising #phase1, #PD01 is ready for #phase2 in H2 2020. https://t.co/HoYPFNa1Qn

Das #MIGFonds 1, 3, 4, 5, 7, 11, 12, 13 & 15 Beteiligungsunternehmen #AFFiRiS hat einen weiteren bedeutenden Meilenstein geschafft: das österreichische #Biotech Unternehmen erhält für sein #Parkinson-Medikament ein #Patent vom chinesischen Patentamt! https://t.co/p6kzjA8QIj
#Affiris is also on #twitter. Follow us to discover our latest news and to know more about our innovative technology to develop specific active #immunotherapies (#SAITs) for patients with #neurodegenerative diseases. #Parkinson #AFFITOME #AFFITOPE


Affiris Announces Phase 2 Study in Parkinson's & New Strategic Focus on Neurodegenerative Diseases https://t.co/qXMBu59R5N #Affiris More Austrian life science business news at [LSG] at https://t.co/7hbfB6h8JK
![iitoLifeScience's tweet photo. Affiris Announces Phase 2 Study in Parkinson's & New Strategic Focus on Neurodegenerative Diseases https://t.co/qXMBu59R5N #Affiris More Austrian life science business news at [LSG] at https://t.co/7hbfB6h8JK https://t.co/t066sQ4I8i](https://pbs.twimg.com/media/EN6ajeaXkAA_siX.jpg)
#Immunotherapy is being developed as a new #treatment for #Parkinsons! 👏#BioArctic #AFFiRiS @ProthenaCorp
https://t.co/RCCQf2DBYS
“One of the key aspects of our approach is that our antibody does not just neutralise these forms of alpha synuclein after it binds to them, but it also helps… the brain clear it very quickly” #immunotherapy #Parkinsons #BioArctic #AFFiRiS @ProthenaCorp
https://t.co/RCCQf2DBYS
#Immunotherapy has the potential to have long-lasting effects, possibly only requiring yearly injections! #Parkinsons #BioArctic #AFFiRiS @ProthenaCorp
https://t.co/RCCQf2DBYS
How can #immunotherapy help #Parkinsons patients? #BioArctic #AFFiRiS
@ProthenaCorp
https://t.co/RCCQf2DBYS
The latest post on the SoPD website looks at immunotherapy approaches to treating #Parkinsons, & reviews the recent results from the Austrian biotech #AFFiRiS regarding their Phase I clinical trial (the press release has one very intriguing sentence)
https://t.co/7qgKURa48b

#Austrian biotech company #AFFiRiS: #ParkinsonsDisease vaccine -clinical results boost prospects https://t.co/MUhN7eTYUR
Vienna-based Biotech raises €10M to fight Metabolic diseases and Parkinson’s #AFFiRiS https://t.co/eIvQNy9nHL

Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.8M followers

Barack Obama 
@barackobama
119.2M followers

Donald J. Trump 
@realdonaldtrump
111.7M followers

Cristiano Ronaldo 
@cristiano
111.1M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
97.8M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91M followers

KATY PERRY 
@katyperry
87.9M followers

Taylor Swift 
@taylorswift13
81.8M followers

Lady Gaga 
@ladygaga
73.3M followers

Virat Kohli 
@imvkohli
70.3M followers

Kim Kardashian 
@kimkardashian
69.9M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
64M followers

Neymar Jr 
@neymarjr
63.1M followers

The Ellen Show
@theellenshow
62.4M followers

CNN 
@cnn
61.9M followers

Selena Gomez 
@selenagomez
61M followers

X 
@x
60.8M followers










